The cellular basis of site-specific tumor metastasis

New England Journal of Medicine

Volumn 322, Issue 9, 1990, Pages 605-612

  Flier, Jeffrey S ^a   Underhill, Lisa H ^a   Zetter, Bruce R ^b  

^a Harvard Medical School ^*

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION; CELL INVASION; CELL MOTILITY; CYTOLOGY; METASTASIS; PRIORITY JOURNAL; REVIEW;

ANIMAL; NEOPLASM METASTASIS; ORGAN SPECIFICITY;

EID: 0025301851     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199003013220907     Document Type: Review

References (71)

1. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889; 1: 571–3.
2. Ewing J. A treatise on tumors. 3rd ed. Philadelphia: W.B. Saunders, 1928.
3. Willis RA. The spread of tumours in the human body. 3rd ed. London: Butterworth, 1973.
4. Sugarbaker EV. Patterns of metastasis in human malignancies. Cancer Biol Rev 1981; 2: 235–303.
5. Graf AH, Buchberger W, Langmayr H, Schmid KW. Site preference of metastatic tumours of the brain. Virchows Archiv [A] 1988; 412: 493–8.
6. Kamenov B, Kieran MW, Barrington-Leigh J, Longenecker BM. Homing receptors as functional markers for classification, prognosis, and therapy of leukemias and lymphomas. Proc Soc Exp Biol Med 1984; 177: 211–9.
7. Hart IR. “Seed and soil” revisited: mechanisms of site-specific metastasis. Cancer Metast Rev 1982; 1: 5–16.
8. Tarin D. Clinical and experimental studies on the biology of metastasis. Biochim Biophys Acta 1985; 780: 227–35.
9. Kinsey DL. An experimental study of preferential metastasis. Cancer 1960; 13: 674–6.
10. Nicolson GL. Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev 1988; 7: 143–88.
11. Deuel TF. Polypeptide growth factors: roles in normal and abnormal cell growth. Annu Rev Cell Biol 1987; 3: 443–92.
12. Horak E, Darling DL, Tarin D. Analysis of organ-specific effects on metastatic tumor formation by studies in vitro. J Natl Cancer Inst 1986; 76: 913–22.
13. Nicolson GL, Dulski KM. Organ specificity of metastatic tumor colonization is related to organ-selective growth properties of malignant cells. Int J Cancer 1986; 38: 289–94.
14. Naito S, Giavazzi R, Fidler IJ. Correlation between the in vitro interactions of tumor cells with an organ environment and metastatic behavior in vivo. Invasion Metastasis 1987; 7: 16–29.
15. Sargent NS, Oestreicher M, Haidvogl H, Madnick HM, Burger MM. Growth regulation of cancer metastases by their host organ. Proc Natl Acad Sci U S A 1988; 85: 7251–5.
16. Cavanaugh PG, Nicolson GL. Purification and some properties of a lung-derived growth factor that differentially stimulates the growth of tumor cells metastatic to the lung. Cancer Res 1989; 49: 3928–33.
17. Roberts AB, Sporn MB. Transforming growth factor beta. Adv Cancer Res 1988; 51: 107–45.
18. Sherry B, Cerami A. Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses. J Cell Biol 1988; 107: 1269–77.
19. Ervin PR Jr, Kaminski MS, Cody RL, Wicha MS. Production of mamma-statin, a tissue-specific growth inhibitor, by normal human mammary cells. Science 1989; 244: 1585–7.
20. Silverberg E, Lubera JA. Cancer statistics, 1989. CA 1989; 39: 3–20.
21. Jacobs SC. Spread of prostatic cancer to bone. Urology 1983; 21: 337–44.
22. Batson OV. The function of the vertebral veins and their role in the spread of metastases. Ann Surg 1940; 112: 138–49.
23. Chackal-Roy M, Niemeyer C, Moore M, Zetter BR. Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow. J Clin Invest 1989; 84: 43–50.
24. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? Cancer Res 1986; 46: 467–73.
25. Weiss L, Orr FW, Honn KV. Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis. Clin Exp Metastasis 1989; 7: 127–67.
26. Liotta LA, Kleinerman J, Saidel GM. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 1974; 34: 997–1004.
27. Nicolson GL, Winkelhake JL. Organ specificity of blood-borne tumour metastasis determined by cell adhesion? Nature 1975; 255: 230–2.
28. Netland PA, Zetter BR. Organ-specific adhesion of metastatic tumor cells in vitro. Science 1984; 224: 1113–5.
29. Netland. Metastatic potential of B16 melanoma cells after in vitro selection for organ-specific adherence. J Cell Biol 1985; 101: 720–4.
30. Greene HSN, Harvey EK. The relationship between the dissemination of tumor cells and the distribution of metastases. Cancer Res 1964; 24: 799–811.
31. Auerbach R, Lu WC, Pardon E, Gumkowski F, Kaminska G, Kaminski M. Specificity of adhesion between murine tumor cells and capillary endothelium: an in vitro correllate of preferential metastasis in vivo. Cancer Res 1987; 47: 1492–6.
32. Kaminski M, Auerbach R. Tumor cells are protected from NK-cell-mediated lysis by adhesion to endothelial cells. Int J Cancer 1988; 41: 847–9.
33. McCarthy JB, Basara ML, Palm SL, Sas DF, Furcht LT. The role of cell adhesion proteins — laminin and fibronectin — in the movement of malignant and metastatic cells. Cancer Metastasis Rev 1985; 4: 125–52.
34. Juliano RL. Membrane receptors for extracellular matrix macromolecules: relationship to cell adhesion and tumor metastasis. Biochim Biophys Acta 1987; 907: 261–78.
35. Doerr R, Zvibel I, Chiuten D, D'Olimpio J, Reid LM. Clonal growth of tumor on tissue-specific biomatrices and correlation with organ site specificity of metastases. Cancer Res 1989; 49: 384–92.
36. Rice GE, Gimbrone MA Jr, Bevilacqua MP. Tumor cell-endothelial interactions: increased adhesion of human melanoma cells to activated vascular endothelium. Am J Pathol 1988; 133: 204–10.
37. Gamble JR, Harlan JM, Klebanoff SJ, Vadas MA. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci U S A 1985; 82: 8667–71.
38. Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA Jr. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest 1985; 76: 2003–11.
39. Pauli BU, Lee CL. Organ preference of metastasis: the role of organspecifically modulated endothelial cells. Lab Invest 1988; 58: 379–87.
40. Roos E, Tulp A, Middelkoop OP, van de Pavert IV. Interactions between lymphoid tumor cells and isolated liver endothelial cells. J Natl Cancer Inst 1984; 72: 1173–80.
41. Roos E, Middelkoop OP, van de Pavert IV. Adhesion of tumor cells to hepatocytes: different mechanisms for mammary carcinoma compared with lymphosarcoma cells. J Natl Cancer Inst 1984; 3: 963–9.
42. Gjøen T, Seljelid R, Kolset SO. Binding of metastatic colon carcinoma cells to liver macrophages. J Leukoc Biol 1989; 45: 362–9.
43. Springer TA, Dustin ML, Kishimoto TK, Marlin SD. The lymphocyte function-associated LFA-1, CD2 and LFA-3 molecules: cell adhesion receptors of the immune system. Annu Rev Immunol 1987; 5: 223–52.
44. Roos E, Roossien FF. Involvement of leukocyte function-associated antigen-1 (LFA-1) in the invasion of hepatocyte cultures by lymphoma and T-cell hybridoma cells. J Cell Biol 1987; 105: 553–9.
45. Roossien FF, de Rijk D, Bikker A, Roos E. Involvement of LFA-1 in lymphoma invasion and metastasis demonstrated with LFA-1-deficient mutants. J Cell Biol 1989; 108: 1979–85.
46. Graf J, Iwamoto Y, Sasaki M, et al. Identification of an amino acid sequence in laminin mediating cell attachment, chemotaxis, and receptor binding. Cell 1987; 48: 989–96.
47. Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science 1987; 238: 491–7.
48. Humphries MJ, Olden K, Yamada KM. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science 1986; 233: 467–70.
49. Iwamoto Y, Robey FA, Graf J, et al. YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation. Science 1987; 238: 1132–4.
50. Gehlsen KR, Argraves WS. Pierschbacher MD, Ruoslahti E. Inhibition of in vitro tumor cell invasion by Arg-GIy-Asp-containing synthetic peptides. J Cell Biol 1988; 106: 925–30.
51. Liotta LA, Stetler-Stevenson W. Metalloproteinases and malignant conversion: does correlation imply causality? J Natl Cancer Inst 1989; 81: 556–7.
52. Sloane BF, Honn KV, Sadler JG, Turner WA, Kimpson JJ, Taylor JD. Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential. Cancer Res 1982; 42: 980–6.
53. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 284: 67–8.
54. Yusa T, Blood CH, Zetter BR. Tumor cell interactions with elastin: implications for pulmonary metastasis. Am Rev Respir Dis 1989; 140: 1458–62.
55. Kao RT, Stem R. Elastases in human breast carcinoma cell lines. Cancer Res 1986; 46: 1355–8.
56. Zeydel M, Nakagawa S, Biempica L, Takahashi S. Collagenase and elastase production by mouse mammary adenocarcinoma primary cultures and cloned cells. Cancer Res 1986; 46: 6438–45.
57. Vlodavsky I, Fuks Z, Bar-Ner M, Ariav Y, Schirrmacher V. Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis. Cancer Res 1983; 43: 2704–11.
58. Nakajima M, Irimura T, Di Ferrante D, Di Ferrante N, Nicolson GL. Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. Science 1983; 220: 611–3.
59. Danø K, Andreasen PA, Grøndahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 1985; 44: 139–266.
60. Hay ED, ed. Cell biology of extracellular matrix. New York: Plenum Press, 1981.
61. Varani J. Chemotaxis of metastatic tumor cells. Cancer Metastasis Rev 1982; 1: 17–28.
62. Zimmerman A, Keller HU. Locomotion of tumor cells as an element of invasion and metastasis. Biomed Pharmacother 1987; 41: 337–44.
63. Liotta LA, Schiffmann E. Tumour motility factors. Cancer Surv 1988; 7: 631–52.
64. Hujanen ES, Terranova VP. Migration of tumor cells to organ-derived chemoattractants. Cancer Res 1985; 45: 3517–21.
65. Mundy GR, DeMartino S, Rowe DW. Collagen and collagen-derived fragments are chemotactic for tumor cells. J Clin Invest 1981; 68: 1102–5.
66. Blood CH, Sasse J, Brodt P, Zetter BR. Identification of a tumor cell receptor for VGVAPG, an elastin-derived chemotactic peptide. J Cell Biol 1988; 107: 1987–93.
67. Magro C, Orr FW, Manishen WJ, Sivananthan K, Mokashi SS. Adhesion, chemotaxis, and aggregation of Walker carcinosarcoma cells in response to products of resorbing bone. J Natl Cancer Inst 1985; 74: 829–38.
68. Damiano VV, Tsang A, Christner P, Rosenbloom J, Weinbaum G. Immunologic localization of elastin by electron microscopy. Am J Pathol 1979; 96: 439–55.
69. Senior RM, Griffin GL, Mecham RP, Wrenn DS, Prasad KU, Urry DW. Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes. J Cell Biol 1984; 99: 870–4.
70. Blood CH, Zetter BR. Membrane-bound protein kinase C modulates receptor affinity and chemotactic responsiveness of Lewis lung carcinoma sublines to an elastin-derived peptide. J Biol Chem 1989; 264: 10614–20.
71. Sher BT, Bargatze R, Holzmann B, et al. Homing receptors and metastasis. Adv Cancer Res 1988; 51: 361–90.